Literature DB >> 7920491

Choices in oncology: factors that influence patients' treatment preference.

G M Kiebert1, A M Stiggelbout, J Kievit, J W Leer, C J van de Velde, H J de Haes.   

Abstract

Medical treatment of cancer often entails a trade-off between outcomes of two different attributes: quality of life (QOL) and length of life (LL). This process of weighing advantages and disadvantages seems to be influenced by different factors. The main purposes of this study were (a) to investigate the relative importance of different factors on the trade-off and (b) to explore the relationship between these importance ratings and personal characteristics. We asked 199 patients with cancer to indicate to what degree they consider a number of factors to be of importance if they had to choose between two treatment modalities that differ in their expected outcomes concerning QOL and LL. The seven factors were their age at the time of decision, having a partner, having children, inability to work due to side-effects of the treatment, the nature of the side-effects, disease-related life expectancy and baseline QOL. The results indicate that six of the seven factors were of considerable to great importance when a treatment choice had to be made. The negative effects of treatment on the ability to work did not seem to be a very important consideration. Patient age and education were positively associated with importance ratings.

Entities:  

Mesh:

Year:  1994        PMID: 7920491     DOI: 10.1007/bf00435382

Source DB:  PubMed          Journal:  Qual Life Res        ISSN: 0962-9343            Impact factor:   4.147


  22 in total

Review 1.  Methodology for measuring health-state preferences--IV: Progress and a research agenda.

Authors:  D G Froberg; R L Kane
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

Review 2.  The use of QALYs in health care decision making.

Authors:  G Loomes; L McKenzie
Journal:  Soc Sci Med       Date:  1989       Impact factor: 4.634

3.  Should QALYs be programme-specific?

Authors:  C Donaldson; A Atkinson; J Bond; K Wright
Journal:  J Health Econ       Date:  1988-09       Impact factor: 3.883

4.  Late effects of adjuvant chemotherapy and postoperative radiotherapy on quality of life among breast cancer patients.

Authors:  G Berglund; C Bolund; T Fornander; L E Rutqvist; P O Sjödén
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

5.  Quality-adjusted life years, utility theory, and healthy-years equivalents.

Authors:  A Mehrez; A Gafni
Journal:  Med Decis Making       Date:  1989 Apr-Jun       Impact factor: 2.583

6.  Economics of coronary artery bypass grafting.

Authors:  A Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-08-03

Review 7.  Utility approach to measuring health-related quality of life.

Authors:  G W Torrance
Journal:  J Chronic Dis       Date:  1987

8.  Effects of framing and level of probability on patients' preferences for cancer chemotherapy.

Authors:  A M O'Connor
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

9.  Effect of peri-operative chemotherapy on the quality of life of patients with early breast cancer.

Authors:  G M Kiebert; J Hanneke; C J de Haes; J Kievit; C J van de Velde
Journal:  Eur J Cancer       Date:  1990       Impact factor: 9.162

Review 10.  Adjuvant therapy of breast cancer. International Breast Cancer Study Group.

Authors:  A Goldhirsch; R D Gelber; M Castiglione
Journal:  Eur J Cancer       Date:  1991       Impact factor: 9.162

View more
  11 in total

1.  Medical Economics and Quality of Life: Analysis of Factors That Influence the Perception of Medical Cost by Post-surgical Breast Cancer Patients.

Authors: 
Journal:  Breast Cancer       Date:  1995-10-31       Impact factor: 4.239

Review 2.  Decision making and quality of life in the treatment of cancer: a review.

Authors:  S Yousuf Zafar; Stewart C Alexander; Kevin P Weinfurt; Kevin A Schulman; Amy P Abernethy
Journal:  Support Care Cancer       Date:  2008-09-19       Impact factor: 3.603

3.  On-going clinical trials for elderly patients with a hematological malignancy: are we addressing the right end points?

Authors:  M E Hamaker; R Stauder; B C van Munster
Journal:  Ann Oncol       Date:  2014-01-23       Impact factor: 32.976

4.  Evaluation and reporting of quality of life outcomes in phase III chemotherapy trials for poor prognosis malignancies.

Authors:  M E Hamaker; K J Schulkes; D Ten Bokkel Huinink; B C van Munster; L H van Huis; F van den Bos
Journal:  Qual Life Res       Date:  2016-07-05       Impact factor: 4.147

5.  A comparison of time trade-off and quality of life measures in patients with advanced cancer.

Authors:  D J Perez; R McGee; A V Campbell; E A Christensen; S Williams
Journal:  Qual Life Res       Date:  1997-03       Impact factor: 4.147

6.  Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study.

Authors:  Karim M Eltawil; Robert Berry; Mohamed Abdolell; Michele Molinari
Journal:  HPB (Oxford)       Date:  2012-05       Impact factor: 3.647

7.  Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.

Authors:  Michelle Y Martin; Maria Pisu; Robert A Oster; Julie M Urmie; Deborah Schrag; Haiden A Huskamp; Jeannette Lee; Catarina I Kiefe; Mona N Fouad
Journal:  Cancer       Date:  2011-04-26       Impact factor: 6.860

8.  Exploratory Factor Analysis of a Patient-Centered Cancer Care Measure to Support Improved Assessment of Patients' Experiences.

Authors:  Kerri-Anne R Mitchell; Kelly J Brassil; Kayo Fujimoto; Bryan M Fellman; Laura Aubree Shay; Andrew E Springer
Journal:  Value Health       Date:  2019-12-09       Impact factor: 5.725

9.  Palliative chemotherapy or best supportive care? A prospective study explaining patients' treatment preference and choice.

Authors:  C G Koedoot; R J de Haan; A M Stiggelbout; P F M Stalmeier; A de Graeff; P J M Bakker; J C J M de Haes
Journal:  Br J Cancer       Date:  2003-12-15       Impact factor: 7.640

10.  Concerns underlying treatment preferences of advanced cancer patients with children.

Authors:  Devon K Check; Eliza M Park; Katherine E Reeder-Hayes; Deborah K Mayer; Allison M Deal; Justin M Yopp; Donald L Rosenstein; Laura C Hanson
Journal:  Psychooncology       Date:  2016-05-26       Impact factor: 3.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.